RH blood group system and molecular basis of Rh-deficiency

Bailliere's Best Practice and Research in Clinical Haematology

Volumn 12, Issue 4, 1999, Pages 655-689

  Cartron, Jean Pierre ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Blood groups; Gene alteration; Membrane complex; Membrane defect; Protein trafficking; Red cells; Rh(null); Rhesus

Indexed keywords

RHESUS ANTIGEN;

BLOOD GROUP RHESUS SYSTEM; GENE MUTATION; HOMOZYGOSITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SILENT GENE; SUPPRESSOR GENE;

EID: 0033506288     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.1999.0047     Document Type: Article

References (179)

1. Levine P, Stetson R E. An unusual case of intragroup agglutination. Journal of the American Medical Association. 113:1939;126-127.
2. Levine P, Burnham L, Katzin E M, Vogel P. The role of iso-immmunization in the pathogenesis of erythroblastosis fetalis. American Journal of Obstetrics and Gynecology. 42:1941;925-937.
3. Levine P, Katzin E M, Burnham L. Isoimmunization in pregnancy, its possible bearing on the etiology of erythroblastosis fetalis. Journal of the American Medical Association. 116:1941;825-827.
4. Bowman J M. Hemolytic disease of the newborn. Garratty G. Immunobiology of Transfusion Medicine. 1994;553-595 M Dekker Publications, New York.
5. Mollison P L, Engelfriet C P, Contreras M. Blood Transfusion in Clinical Medicine. 1993;Blackwell, London. p. 204-245.
6. Daniels G L. Human Blood Groups. 1995;Blackwell Science Ltd, Oxford. p. 257-355.
7. Issitt P D, Anstee D J. Applied Blood Group Serology. 1998;Montgomery Scientific Publications, Durham. p. 315-423.
8. Schmidt P J, Vos G H. Multiple phenotypic abnormalities associated with Rh-null ( - - - / - - - ). Vox Sanguinis. 13:1967;18-20.
9. null. Blood. 36:1970;310-320.
10. Green F A. Studies on the Rh(D) antigen. Vox Sanguinis. 10:1965;32-53.
11. Green F A. Erythrocyte membrane sulfhydryl groups and Rh antigen activity. Immunochemistry. 4:1967;247-257.
12. Green F A. Phospholipid requirements for Rh antigenic activity. Journal of Biological Chemistry. 243:1968;5519-5524.
13. Green F A. Erythrocyte membrane lipids and Rh antigen activity. Journal of Biological Chemistry. 247:1972;881-887.
14. Daniels G L, Anstee D J, Cartron J P. Blood group terminology 1995. IISBT working party on terminology for red cell surface antigens. Vox Sanguinis. 69:1995;265-279.
15. a. Nature, London. 295:1982;529-531.
16. Gahmberg C G. Molecular identification of the human Rho(D)-antigen. FEBS Letters. 140:1982;93-97.
17. Gahmberg C G, Khari K K. Association of Rh(D) polypeptides with the membrane skeleton in Rh(D) positive cells. Journal of Immunology. 133:1984;334-337.
18. Ridgwell K, Tanner M JA, Anstee D J. The rhesus (D) polypeptide is linked to the human erythrocyte cytoskeleton. FEBS Letters. 174:1984;7-10.
19. Moore S, Green C. The identification of specific Rhesus polypeptide blood group ABH active glycoprotein complexes in the human red cell membrane. Biochemical Journal. 244:1987;735-741.
20. Gahmberg C G. Molecular characterization of the human red-cell Rho(D) antigen. EMBO Journal. 2:1983;223-227.
21. von dem Borne A EG, Bos M JE, Lomas C. Murine monoclonal antibodies against a unique determinant of erythrocytes related to Rh and U antigens. British Journal of Haematology. 75:1990;254-261.
22. Mallinson G, Anstee D J, Avent N D. Murine monoclonal antibody MB-2D10 recognizes Rh-related glycoproteins in the human red cell membrane. Transfusion. 30:1990;222-225.
23. Agre P, Cartron J P. Molecular biology of Rh antigens. Blood. 78:1991;551-563.
24. Cartron J P, Agre P. Rh blood group antigens: protein and gene structure. Seminars in Hematology. 30:1993;193-208.
25. Anstee D J, Tanner M JA. Biochemical aspects of the blood group Rh (rhesus) antigens. Baillère's Clinical Haematology. 6:1993;401-422.
26. Cartron J P. Defining the Rh blood group antigens. Biochemistry and molecular genetics. Blood Reviews. 8:1994;199-212.
27. null. Hématologie. 3:1997;207-220.
28. Huang C H. Molecular insights into the Rh protein family and associated antigens. Current Opinion in Haematology. 4:1997;94-103.
29. Cartron J P, Bailly P, Le Van Kim C. Insights into the structure and function of membrane polypeptides carrying blood group antigens. Vox Sanguinis. 74:1998;29-64.
30. Colin Y, Chérif-Zahar B, Le Van Kim C. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood. 78:1991;2747-2752.
31. Andrews K T, Wolter L C, Saul A, Hyland C A. The RhD-trait in a white patient with the RhCCee phenotype attributed to a four-nucleotide deletion in the RHD gene. Blood. 92:1998;1839-1840.
32. Blunt T, Daniels G, Carritt B. Serotype switching in a partially deleted RhD gene. Vox Sanguinis. 67:1994;397-401.
33. Umenishi F, Kajii E, Ikemoto S. Molecular analysis of Rh polypeptides in a family with RhD-positive and RhD-negative phenotypes. Biochemical Journal. 299:1994;207-211.
34. Huang C H. Alteration of RH gene structure and expression in human dCCee and DCw- red blood cells: phenotypic homozygosity versus genotypic heterozygosity. Blood. 88:1996;2326-2333.
35. u), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood. 89:1997;2568-2577.
36. Aubin J T, Le Van Kim C, Mouro I. Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. British Journal of Haematology. 98:1997;356-364.
37. Okuda H, Kawano M, Iwamoto S. The RHD gene is highly detectable in RhD-negative Japanese donors. Journal of Clinical Investigation. 100:1997;373-379.
38. Chérif-Zahar B, Bony V, Steffensen R. Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic mylocytic leukemia. British Journal of Haematology. 102:1998;1263-1270.
39. Arce M, Thompson E S, Wagner S. Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood. 82:1993;651-655.
40. Matassi G, Chérif-Zahar B, Mouro I, Cartron J P. Characterization of the recombination hot spot involved in the genomic rearrangement leading to the hybridD-CE-D gene in the D(VI) phenotype. American Journal of Human Genetics. 60:1997;808-817.
41. Fisher R A, Race R R. Rh gene frequencies in Britain. Nature, London. 157:1946;48-49.
42. Fisher R A. The Rhesus factor. American Scientist. 35:1947;95-102.
43. Carritt B, Kemp T J, Poulter M. Evolution of the human RH (rhesus) blood group genes: a 50 year old prediction (partially) fulfilled. Human Molecular Genetics. 6:1997;843-850.
44. Fujiwara H, Okuda H, Omi T. The STR polymorphisms in intron 8 may provide information about the molecular evolution of RH haplotypes. Human Genetics. 104:1999;301-306.
45. Okuda H, Suganuma H, Tsudo N. Sequence analysis of the spacer region between the RHD and RHCE genes. Biochemical and Biophysical Research Communications. 263:1999;378-383.
46. Mouro I, Colin Y, Chérif-Zahar B. Molecular genetic basis of the human Rhesus blood group system. Nature Genetics. 5:1993;62-65.
47. Gr variant. British Journal of Haematology. 93:1996;472-474.
48. Smythe J S, Avent N D, Judson P A. Expression of RHD and RHCE gene products using retroviral transduction of K562 cells establishes the molecular basis of Rh blood group antigens. Blood. 87:1996;2968-2973.
49. Iwamoto S, Yamasali M, Kawano M. Expression analysis of human rhesus blood group antigens by gene transduction into erythroid and non-erythroid cells. International Journal of Haematology. 68:1998;257-268.
50. Le Van Kim C, Mouro I, Chérif-Zahar B. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proceedings of the National Academy of Sciences of the USA. 89:1992;10 925-10 929.
51. Tippett P, Lomas-Francis C, Wallace M. The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sanguinis. 70:1996;123-131.
52. Faas B HW, Beckers E AM, Maaskant-van Wijk P A. Molecular characterization of qualitative Rh variants. Biotest Bulletin. 5:1997;439-449.
53. Cartron J P, Rouillac C, Le Van Kim C. Tentative model for the mapping of D epitopes on the RhD polypeptide. Transfusion Clinique et Biologique. 6:1996;497-503.
54. Jones J, Scott M L, Voak D. Monoclonal anti-D specificity and Rh structure: criteria for selection of monoclonal anti-D reagents for routine typing of patients and donors. Transfusion Medicine. 5:1995;171-184.
55. Scott M L, Voak D, Jones J W. A model for RhD- the relationship of 30 serologically defined epitopes to predicted structure. Biotest Bulletin. 5:1997;459-466.
56. Liu W, Smythe J S, Scott M L. Site-directed mutagenesis of the human D antigen: definition of D epitopes on the sixth external domain of the D protein expressed on K562 cells. Transfusion. 39:1999;17-25.
57. Zhu A, Haller S, Li H. Use of RhD fusion protein expressed on K562 cell surface in the study of molecular basis for D antigenic epitopes. Journal of Biological Chemistry. 274:1999;5731-5737.
58. Chang T Y, Siegel D. Genetic and immunological properties of phage-displayed human anti-Rh(D) antibodies: implication for Rh(D) epitope topology. Blood. 91:1998;3066-3078.
59. Chang T Y, Siegel D. Epitope migration of anti-D antibodies. Transfusion. 38:1998;61S.
60. Matassi G, Chérif-Zaher B, Raynal V. Organisation of the human RH50A gene (RHAG) and evolution of base composition of theRH gene family. Genomics. 47:1998;286-293.
61. nulldisease. Journal of Biological Chemistry. 273:1998;2207-2213.
62. deVetten M P, Agre P. The Rh polypeptide is a major fatty acid acylated erythrocyte membrane protein. Journal of Biological Chemistry. 263:1998;18 193-18 196.
63. Hartel-Schenk S, Agre P. Mammalian red cell membrane Rh polypeptides are selectively palmitoylated subunits of a macromolecular complex. Journal of Biological Chemistry. 267:1992;5569-5574.
64. Smythe J S, Anstee D J. K562 cells expressing RhD polypeptide with a Cys285 to Ala mutation have a normal D antigen. Transfusion Medicine. 7:1997;29.
65. Avent N D, Liu W, Warner K M. Immunochemical analysis of the human erythrocyte Rh polypeptides. Journal of Biological Chemistry. 271:1996;14 233-14 239.
66. Eyers S A, Ridgwell K, Mawby W J, Tanner M J. Topology and organization of human Rh (rhesus) blood group-related polypeptides. Journal of Biological Chemistry. 269:1994;6417-6423.
67. Matassi G, Chérif-Zahar B, Pesole G. The members of the RH gene family (RH50 and RH30) followed different evolutionary pathways. Journal of Molecular Evolution. 48:1999;151-159.
68. Kitano T, Sumyama K, Shiroishi T, Saitou N. Conserved evolution of the RH50 gene compared to its homologous Rh blood group gene. Biochemical and Biophysical Research Communications. 249:1998;78-85.
69. Westhoff C M, Wylie D E. Investigation of the human Rh blood group system in nonhuman primates and other species with serologic and Southern blot analysis. Journal of Molecular Evolution. 39:1994;87-92.
70. Socha W W, Ruffié J. The rhesus system. Socha W W, Ruffié J. Blood Groups of Primates: Theory, Practice and Evolutionary Meaning. 1983;75-90 Alan R Liss, New York.
71. Blancher A, Socha W W. The Rhesus system. Blancher A, Klein J, Socha W W. Molecular Biology and Evolution of Blood Group and MHC antigens in Primates. 1997;147-218 Springer-Verlag, Berlin.
72. Wilson R, Ainscough R, Anderson K. 2·2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature, London. 368:1994;32-38.
73. Seack J, Pancer Z, Muller I M, Muller W E. Molecular cloning and primary structure of a Rhesus (Rh)-like protein from the marine sponge Geodia cydonium. Immunogenetics. 46:1997;493-498.
74. +transporters. Trends in Biochemical Sciences. 22:1997;460-461.
75. Lorenz M C, Heitman J. The MEP2 ammonium permease regulates pseudohyphal differentiation in Saccharomyces cerevisiae. EMBO Journal. 17:1998;1236-1247.
76. Vos G H, Vos D, Kirk R L, Sanger R. A sample of blood with no detectable Rh antigens. Lancet. i:1961;14-15.
77. Race R R, Sanger R. The Rh blood groups. Race R R, Sanger R. Blood Groups in Man. 1975;178-260 Blackwell, Oxford.
78. null. Nature, London. 204:1964;892-893.
79. nullblood. Transfusion. 5:1965;492-500.
80. Chown B, Lewis M, Kaita H, Lowen B. An unlinked modifier of Rh blood groups: effects when heterozygous and homozygous. American Journal of Human Genetics. 24:1972;623-637.
81. null. Transfusion. 7:1967;33-34.
82. nulldisease. Proceedings of the 12th Congress of the International Society for Blood Transfusion, Moscow 1969. 1971;Karger, Basel. p. 230-233.
83. nulldisease. Vox Sanguinis. 23:1972;182-189.
84. Nash R, Shojania A M. Hematological aspect of Rh deficiency syndrome: a case report and a review of the literature. American Journal of Hematology. 24:1987;267-275.
85. Issitt P D. Null red blood cell phenotypes: associated biological changes. Transfusion Medicine Reviews. 7:1993;139-155.
86. Chapman R C. Red cell life-span after splenectomy in hereditary spherocytosis. Journal of Clinical Investigation. 47:1968;2263-2267.
87. nullred blood cells. Blood. 48:1976;457-468.
88. nullsyndrome. Blood. 63:1984;1046-1055.
89. nullhuman erythrocytes have an abnormal membrane phospholipid organization. Biochemical Journal. 221:1984;931-934.
90. Bailly P, Cartron J P, Wang D, Johnson R M. Hereditary stomatocytosis and Rh-deficient patients exhibit distinct molecular defects. Blood. 50:1992;1624-1626.
91. Zhu Y, Pastzy C, Turesky T. Stomatocytosis is absent in 'stomatin'-deficient murine red blood cells. Blood. 93:1999;2404-2410.
92. Tippett P. Regulator genes affecting red cell antigens. Transfusion Medicine Reviews. 4:1990;56-68.
93. nullerythrocytes. Blut. 54:1987;13-24.
94. nullhuman erythrocytes. Biochemical Journal. 213:1983;267-269.
95. Chérif-Zahar B, Raynal V, Gane P. Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency. Nature Genetics. 12:1996;168-173.
96. Campbell I G, Freemont P S, Foulkes W, Trowsdal J. An ovarian tumor marker with homology to vaccinia virus containing an IgV-like region and multiple transmembrane domains. Cancer Research. 52:1992;5416-5420.
97. nullhuman erythrocytes. Biochemical Journal. 251:1988;499-505.
98. Schwartz M A, Brown E J, Fazeli B. A 50 kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. Journal of Biological Chemistry. 268:1993;19 931-19 934.
99. Cooper D, Lindberg F P, Gamble J R. Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proceedings of the National Academy of Sciences of the USA. 92:1995;3978-3982.
100. Gao A G, Lindberg F P, Finn M B. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. Journal of Biological Chemistry. 271:1996;21-24.
101. Ticchioni M, Deckert M, Mary F. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. Journal of Immunology. 158:1997;677-684.
102. Lindberg F P, Lublin D M, Telen M J. Rh-related antigen CD47 is the signal transducer integrin-associated protein. Journal of Biological Chemistry. 269:1994;1567-1570.
103. Poss M T, Swansson J L, Telen M J. Monoclonal antibody recognizing a unique Rh-related specificity. Vox Sanguinis. 64:1993;231-239.
104. Bailly P, Hermand P, Callebault I. The LW blood group glycoprotein is homologous to intercellular adhesion molecules. Proceedings of the National Academy of Sciences of the USA. 91:1994;5306-5310.
105. Bailly P, Tontti E, Hermand P. The red cell LW blood group glycoprotein is an intracellular adhesion molecule (ICAM-4) which binds to CD11/CD18 leucocyte integrins. European Journal of Immunology. 25:1995;3316-3320.
106. Spring F A, Olsson M L, Parsons S F, Anstee D J. LW glycoprotein an erythroid specific member of the ICAM family, is a ligand for α4β1. Blood. 92:1998;589a.
107. Cartron J P, Rahuel C. Human erythrocyte glycophorins: protein and gene structure analysis. Transfusion Medicine Reviews. 6:1992;63-92.
108. Fukuda M. Molecular genetics of the glycophorin A gene cluster. Seminars in Hematology. 30:1993;138-151.
109. Ridgwell K, Eyers S AC, Mawby W J. Studies on the glycoprotein associated with Rh (rhesus) blood group antigen expression in the human red blood cell membrane. Journal of Biological Chemistry. 269:1994;6410-6416.
110. Bruce L J, Ring S M, Anstee D J. Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte Band 3: a site of interaction between Band 3 and glycophorin A under certain conditions. Blood. 85:1995;541-547.
111. Beckmann R, Smythe J S, Anstee D J, Tanner M JA. Functional cell surface expression of Band 3, the human red blood cell anion exchanger protein (AE1), in K562 erythroleukemia cells: Band 3 enhances the cell surface reactivity of Rh antigens. Blood. 92:1998;4428-4438.
112. Hadley T J, Peiper S C. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood. 89:1997;3077-3091.
113. Lachgar A, Jaureguiberry G, Buenac H L. Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines. Biomedical Pharmacotherapy. 52:1998;436-439.
114. Cartron J P. Recent advances in the biochemistry of blood group antigens. Rouger P, Salmon Ch. Monoclonal Antibodies against Human Red Blood Cell and Related Antigens. 1987;69-97 Librairie Arnette, Paris.
115. Folkerd E D, Ellory J C, Hughes-Jones N C. A molecular size determination of Rh(D) antigen by radiation inactivation. Immunochemistry. 14:1977;529-531.
116. Bloy C, Blanchard D, Hermand P. Properties of the blood group LW glycoprotein and preliminary comparison with Rh proteins. Molecular Immunology. 26:1989;1013-1019.
117. Cochet S, Blancher A, Roubinet F. Immunopurification of the blood group RhD protein from human erythrocyte membranes. Journal of Chromatography. 735:1999;207-217.
118. o(D) antigen. Journal of Immunology. 137:1986;240-244.
119. Discher D E, Mohandas N, Evans E A. Molecular maps of red cell deformation: hidden elasticity and in situ connectivity. Science. 266:1994;1032-1035.
120. Knowles D W, Tilley L, Mohandas N, Chasis J A. Erythrocyte membrane vesiculation: model for the molecular mechanism of protein sorting. Proceedings of the National Academy of Sciences of the USA. 94:1997;12 969-12 974.
121. Peters L L, Shivdasani R A, Liu S C. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell. 86:1996;917-927.
122. Southgate C D, Chishti A H, Mitchell B. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nature Genetics. 14:1996;227-230.
123. Lazarides E. From genes to structural morphogenesis: the genesis and epigenesis of a red blood cell. Cell. 51:1987;345-356.
124. Alloisio N, Dalla Venezia N, Rana N. Evidence that red blood cell p55 may participate in the skeleton-membrane linkage that involves protein 4·1 and glycophorin C. Blood. 82:1993;1323-1327.
125. Lindberg F P, Bullord D C, Caver T E. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science. 274:1996;795-798.
126. Gotoda T, Yamada N, Murase T. Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency. Journal of Biological Chemistry. 266:1991;24 757-24 762.
127. Berget S M. Exon recognition in vertebrate splicing. Journal of Biological Chemistry. 270:1995;2411-2414.
128. Maquat L E. Defects in RNA splicing and the consequence of shortened translational reading frames. American Journal of Human Genetics. 59:1996;279-286.
129. Cooper T A, Mattox W. The regulation of splice-site selection, and its role in human disease. American Journal of Human Genetics. 61:1997;250-266.
130. Chérif-Zahar B, Matassi G, Raynal V. Rh-deficiency of the regulator type caused by splicing mutations in the human RH50 gene. Blood. 92:1998;2535-2540.
131. nullphenotype. Annals of Human Genetics. 62:1998;107-113.
132. nullblood donor of the regulator type. Blood. 91:1998;1458-1463.
133. nullblood donor. Vox Sanguinis. 76:1999;247-248.
134. nulldisease: a silent splice donor is trans to a Gly279→Glu missense mutation in the conserved transmembrane segment. Blood. 92:1998;1776-1784.
135. nullsyndrome: identification of three new missense mutations in the Rh50 glycoprotein gene. American Journal of Hematology. 62:1999;25-32.
136. modsyndrome: a family study of the translation-initiator mutation in the Rh50 glycoprotein gene. American Journal of Human Genetics. 64:1999;108-117.
137. Cartron J P, Le Van Kim C, Colin Y. Glycophorin C and related glycoproteins: structure, function and regulation. Seminars in Hematology. 30:1993;152-158.
138. Le Van Kim C, Piller V, Cartron J P, Colin Y. Glycophorin C and D are generated by the use of alternative translation initiation sites. Blood. 88:1996;2364-2365.
139. Ridgwell K, Spurr N K, Laguda B. Isolation of cDNA clones for a 50 kDa glycoprotein of the human erythrocyte membrane associated with Rh (rhesus) blood-group antigen expression. Biochemical Journal. 287:1992;223-228.
140. nullerythrocytes. Journal of Biological Chemistry. 267:1992;26 050-26 055.
141. Macintosh I, Hamosh A, Dietz C H. Nonsense mutations and diminished mRNA levels. Nature Genetics. 4:1993;219.
142. Maquat L E. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA. 1:1995;453-465.
143. Aoufouchi S, Yélamos J, Milstein C. Nonsense mutations inhibit RNA splicing in a cell-free system: recognition of a mutant codon is independent of protein synthesis. Cell. 85:1996;415-422.
144. Bonifacio J S, Lippincott-Schwartz J. Degradation of proteins within the endoplasmic reticulum. Current Opinion in Cell Biology. 3:1991;592-600.
145. Brodsky J L, McCracken A A. ER-associated and proteasome-mediated protein degradation: how two topologically restricted events came together. Trends in Cell Biology. 7:1997;151-156.
146. Deen P MT, Croes H, van Aubel R AMH. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. Journal of Clinical Investigation. 95:1995;2291-2296.
147. Cheng S H, Gregory R J, Marshall J. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 63:1990;827-834.
148. Tournamille C, Le Van Kim C, Gane P. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fyx individuals. Blood. 92:1998;2147-2156.
149. Olsson M L, Smythe J S, Hansson C. The Fyx phenotype is associated with a missense mutation in the Fyb allele predicting Arg89Cys in the Duffy protein. British Journal of Haematology. 103:1998;1184-1191.
150. Wagner F, Gassner C, Müller T H. Molecular basis of weak D phenotypes. Blood. 93:1999;385-393.
151. nullfamily caused by a silent Rh gene: hematological, serological, and biochemical studies. American Journal of Hematology. 40:1992;306-312.
152. Chérif-Zahar B, Matassi G, Raynal V. Molecular defects of the RHCE gene in Rh-deficient individuals of the amorph type. Blood. 92:1998;639-646.
153. nulldisease: the amorph type results from a novel double mutation in RhCe gene on D-negative background. Blood. 92:1998;664-671.
154. Szostack J W, Orr-Weaver T L, Rothstein R J. The double-strand-break repair model for recombination. Cell. 33:1983;25-35.
155. Chérif-Zahar B, Le Van Kim C, Rouillac C. Organization of the gene (RHCE) encoding the human blood group RhCcEe antigens and characterization of the promoter region. Genomics. 19:1994;68-74.
156. Kajii E, Umenishi F, Omi T, Ikemoto S. Intricate combinatorial patterns of exon splicing generate multiple Rh-related isoforms in human erythroid cells. Human Genetics. 95:1995;657-665.
157. Apoil P A, Reid M E, Halverson G. A human monoclonal anti-D antibody which detects a non conformation dependent epitope on the RhD protein by immunoblot. British Journal of Haematology. 98:1997;365-374.
158. Hermand P, Gane P, Mattei M G. Molecular basis of the LWa/LWb blood group polymorphism. Blood. 86:1995;1590-1594.
159. Lindberg F P, Gresham H D, Reinhold M I, Brown E J. Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding. Journal of Cell Biology. 134:1996;1313-1322.
160. Iwamoto S, Yamasaki M, Kawano M. Expression analysis of human rhesus blood group antigens by gene transduction into erythroid and non-erythroid cells. International Journal of Hematology. 68:1998;257-268.
161. Mouro I, Raynal V, Gane P. Expression of the RhD antigen in K562 cells after a standard transfection procedure coupled with a magnetic beads sorting technique. Vox Sanguinis. 74:1998;1328.
162. Suyama K, Lunn R, Smith B, Haller S. Expression of the Rh-related glycoprotein (Rh50). Acta Haematologica. 100:1998;181-186.
163. Anstee D J, Holmes C H, Judson P A, Tanner M JA. The use of monoclonal antibodies to determine the distribution of red cell surface proteins on cells and tissues. Agre P C, Cartron J P. Protein Blood Group Antigens of the Human Red Cell. 1992;170-181 The Johns Hopkins University Press, Baltimore.
164. Suyama K, Lunn R, Haller S, Goldstein J. Rh(D) antigen expression and isolation of a new Rh(D) cDNA isoform in human erythroleukemic K562 cells. Blood. 84:1994;1975-1981.
165. Southcott M JG, Tanner M JA, Anstee D J. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood. 93:1999;4425-4435.
166. Bony V, Gane P, Bailly P, Cartron J P. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. British Journal of Haematology. 107:1999;263-274.
167. Russo D C, Lee S, Reid M, Redman C. Topology of Kell blood group protein and the expression of multiple antigens by transfected cells. Blood. 84:1994;3518-3523.
168. Russo D, Lee S, Redman C. Intracellular assembly of Kell and Kx blood group proteins. Biochimica et Biophysica Acta. 1461:1999;10-18.
169. Redman C, Marsh W L. The Kell blood group system and the McLeod phenotype. Seminars in Haematology. 30:1993;209-218.
170. Carbonnet F, Hattab C, Collec E. Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides. British Journal of Haematology. 96:1997;857-863.
171. Liu Z, Chen Y, Huang C H. Insertion of Rh30 polypeptides in the plasma membrane does not require coexpression of Rh50 glycoprotein. Blood. 94:1999;188a.
172. Shinitzky M, Souroujon M. Passive modulation of blood group antigens. Proceedings of the National Academy of Sciences of the USA. 76:1979;4438-4440.
173. Schroit A J, Bloy C, Connor J, Cartron J P. Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry. Biochemistry. 29:1990;10 303-10 306.
174. nullerythrocytes. Blood. 76:1990;1021-1027.
175. Geldwerth D, Cherif-Zahar B, Helley D. Phosphatidylserine exposure and aminophospholipid translocase activity in Rh-deficient erythrocytes. Molecular Membrane Biology. 14:1997;125-132.
176. Tang X, Halleck M S, Schlegel R A, Williamson P L. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science. 272:1996;1495-1497.
177. Mouro I, Halleck M S, Schelegel R A. Cloning, expression, and chromosomal mapping of a human ATPase II gene, member of the third subfamily of P-type ATPases and orthologous to the presumed bovine and murine aminophospholipid translocase. Biochemical and Biophysical Research Communications. 257:1999;333-339.
178. Bruckheimer E M, Gillum K D, Schroit A J. Colocalization of Rh polypeptides and the aminophospholipid transporter in dilaurylphosphatidylcholine-induced erythrocyte vesicles. Biochimica et Biophysica Acta. 1235:1995;147-154.
179. +transport in the kidney. Kidney International. 33:1991;S95-S102.